Treatment landscape of triple-negative breast cancer—expanded options, evolving needs

G Bianchini, C De Angelis, L Licata… - Nature reviews Clinical …, 2022 - nature.com
Tumour heterogeneity and a long-standing paucity of effective therapies other than
chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype …

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications

K Asleh, N Riaz, TO Nielsen - Journal of Experimental & Clinical Cancer …, 2022 - Springer
As the field of translational 'omics has progressed, refined classifiers at both genomic and
proteomic levels have emerged to decipher the heterogeneity of breast cancer in a clinically …

Gender-specific impact of sex hormones on the immune system

F Sciarra, F Campolo, E Franceschini… - International journal of …, 2023 - mdpi.com
Sex hormones are key determinants of gender-related differences and regulate growth and
development during puberty. They also exert a broad range modulation of immune cell …

Targeting breast cancer: An overlook on current strategies

D Iacopetta, J Ceramella, N Baldino… - International Journal of …, 2023 - mdpi.com
Breast cancer (BC) is one of the most widely diagnosed cancers and a leading cause of
cancer death among women worldwide. Globally, BC is the second most frequent cancer …

CBP/p300: critical co-activators for nuclear steroid hormone receptors and emerging therapeutic targets in prostate and breast cancers

AR Waddell, H Huang, D Liao - Cancers, 2021 - mdpi.com
Simple Summary The CREB-binding protein (CBP) and p300 are paralogous lysine
acetyltransferases that serve as critical co-activators for transcription factors involved in …

Androgen receptor as an emerging feasible biomarker for breast cancer

CP You, MH Leung, WC Tsang, US Khoo, H Tsoi - Biomolecules, 2022 - mdpi.com
Biomarkers can be used for diagnosis, prognosis, and prediction in targeted therapy. The
estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) are …

[HTML][HTML] Targeting triple-negative breast cancer: A clinical perspective

LS Popovic, G Matovina-Brko, M Popovic… - Oncology …, 2023 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is a disease with often an aggressive course and a
poor prognosis compared to other subtypes of breast cancer. TNBC accounts for …

Development of a Novel Amplifiable System to Quantify Hydrogen Peroxide in Living Cells

L Wang, H Lin, B Yang, X Jiang, J Chen… - Journal of the …, 2024 - ACS Publications
Although many redox signaling molecules are present at low concentrations, typically
ranging from micromolar to submicromolar levels, they often play essential roles in a wide …

What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis?

C Raine, I Giles - Frontiers in Medicine, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease and has a
female predominance of around 3: 1. The relationship between sex hormones and RA has …

The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma

SE Lamhamedi-Cherradi, M Maitituoheti… - Nature …, 2022 - nature.com
Desmoplastic small round cell tumor (DSRCT) is an aggressive, usually incurable sarcoma
subtype that predominantly occurs in post-pubertal young males. Recent evidence suggests …